BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29066385)

  • 1. Nebulized coenzyme Q
    Rossi I; Sonvico F; McConville JT; Rossi F; Fröhlich E; Zellnitz S; Rossi A; Del Favero E; Bettini R; Buttini F
    Eur J Pharm Sci; 2018 Feb; 113():159-170. PubMed ID: 29066385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TPGS-chitosome as an effective oral delivery system for improving the bioavailability of Coenzyme Q10.
    Shao Y; Yang L; Han HK
    Eur J Pharm Biopharm; 2015 Jan; 89():339-46. PubMed ID: 25542680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lecithin/TPGS-based spray-dried self-microemulsifying drug delivery systems: In vitro pulmonary deposition and cytotoxicity.
    Ishak RA; Osman R
    Int J Pharm; 2015 May; 485(1-2):249-60. PubMed ID: 25772421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose coenzyme Q10-loaded oleogels for oral therapeutic supplementation.
    Masotta NE; Martinefski MR; Lucangioli S; Rojas AM; Tripodi VP
    Int J Pharm; 2019 Feb; 556():9-20. PubMed ID: 30529659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of lyoprotectants for the stabilization of biodegradable nanoparticles on the performance of air-jet, ultrasonic, and vibrating-mesh nebulizers.
    Beck-Broichsitter M; Kleimann P; Schmehl T; Betz T; Bakowsky U; Kissel T; Seeger W
    Eur J Pharm Biopharm; 2012 Oct; 82(2):272-80. PubMed ID: 22820646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficiency of emulsifier-free emulsions and emulsions containing rapeseed lecithin as delivery systems for vectorization and release of coenzyme Q10: physico-chemical properties and in vitro evaluation.
    Kaci M; Arab-Tehrany E; Dostert G; Desjardins I; Velot E; Desobry S
    Colloids Surf B Biointerfaces; 2016 Nov; 147():142-150. PubMed ID: 27497933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of aqueous dispersions of Coenzyme Q
    Carvalho TC; McCook JP; Narain NR; McConville JT
    Int J Pharm; 2016 Dec; 514(2):407-419. PubMed ID: 27732894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of nutraceutical coenzyme Q10 nanoemulsion with improved skin permeability and anti-wrinkle efficiency.
    El-Leithy ES; Makky AM; Khattab AM; Hussein DG
    Drug Dev Ind Pharm; 2018 Feb; 44(2):316-328. PubMed ID: 29096550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boosting the aerodynamic properties of vibrating-mesh nebulized polymeric nanosuspensions.
    Beck-Broichsitter M; Knuedeler MC; Oesterheld N; Seeger W; Schmehl T
    Int J Pharm; 2014 Jan; 459(1-2):23-9. PubMed ID: 24286921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic aging of degradable nanosuspension ameliorates vibrating-mesh nebulizer performance.
    Dalla-Bona AC; Schmehl T; Gessler T; Seeger W; Beck-Broichsitter M
    Drug Dev Ind Pharm; 2015; 41(10):1704-9. PubMed ID: 25519975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of coenzyme Q
    Ehrenhaus Masotta N; Höcht C; Contin M; Lucangioli S; Rojas AM; Tripodi VP
    Int J Pharm; 2020 May; 582():119315. PubMed ID: 32283195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
    Elhissi AM; Faizi M; Naji WF; Gill HS; Taylor KM
    Int J Pharm; 2007 Apr; 334(1-2):62-70. PubMed ID: 17123757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation.
    Hong C; Dang Y; Lin G; Yao Y; Li G; Ji G; Shen H; Xie Y
    Int J Pharm; 2014 Dec; 477(1-2):251-60. PubMed ID: 25445518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
    Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
    J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization.
    Nasr M; Najlah M; D'Emanuele A; Elhissi A
    Int J Pharm; 2014 Jan; 461(1-2):242-50. PubMed ID: 24275446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of potent oral nanoparticulate formulation of coenzyme Q10 for treatment of hypertension: can the simple nutritional supplements be used as first line therapeutic agents for prophylaxis/therapy?
    Ankola DD; Viswanad B; Bhardwaj V; Ramarao P; Kumar MN
    Eur J Pharm Biopharm; 2007 Sep; 67(2):361-9. PubMed ID: 17452099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling the droplet size of formulations nebulized by vibrating-membrane technology.
    Beck-Broichsitter M; Knuedeler MC; Seeger W; Schmehl T
    Eur J Pharm Biopharm; 2014 Aug; 87(3):524-9. PubMed ID: 24657823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of atomization technique on the stability and transport efficiency of nebulized liposomes harboring different surface characteristics.
    Lehofer B; Bloder F; Jain PP; Marsh LM; Leitinger G; Olschewski H; Leber R; Olschewski A; Prassl R
    Eur J Pharm Biopharm; 2014 Nov; 88(3):1076-85. PubMed ID: 25460154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porous mannitol carrier for pulmonary delivery of cyclosporine A nanoparticles.
    Leung SS; Wong J; Guerra HV; Samnick K; Prud'homme RK; Chan HK
    AAPS J; 2017 Mar; 19(2):578-586. PubMed ID: 28070713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kolliphor® HS 15 Micelles for the Delivery of Coenzyme Q10: Preparation, Characterization, and Stability.
    Liu L; Mao K; Wang W; Pan H; Wang F; Yang M; Liu H
    AAPS PharmSciTech; 2016 Jun; 17(3):757-66. PubMed ID: 26340950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.